Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology

Obesity

Volumn 21, Issue 4, 2013, Pages 659-664

  Johnson, Richard J ^a   Stenvinkel, Peter ^b   Martin, Sandra L ^c   Jani, Alkesh ^a   Sánchez Lozada, Laura Gabriela ^a,d   Hill, James O ^e   Lanaspa, Miguel A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF COLORADO   (United States)

^d Department of Biochemistry   (Mexico)

^e Nutrition Obesity Research Center at the University of Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; TRIACYLGLYCEROL; URATE OXIDASE;

ABDOMINAL OBESITY; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; GENETIC PREDISPOSITION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; METABOLIC SYNDROME X; NONHUMAN; PATHOGENESIS; REVIEW; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANIMALS; BLOOD PRESSURE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY, ABDOMINAL; PHYSIOLOGY, COMPARATIVE; TRIGLYCERIDES;

ANIMALIA;

EID: 84878290380     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20026     Document Type: Review

References (81)

1. Kylin E., Studies of the hypertension-hyperglycemia-hyperuricemia syndrome Studien uber das Hypertonie-Hyperglykamie-hyperurikamiesyndrome. Zentralblatt fur innere Medizin 1923; 44: 105-127.
2. Herman JB, Medalie JH, Goldbourt U., Diabetes, prediabetes and uricaemia. Diabetologia 1976; 12: 47-52.
3. Haller H., Epidemiology and associated risk factors of hyperlipoproteinemia. Z Gesamte Inn Med 1977; 32: 124-128.
4. Phillips GB., Relationship between serum sex hormones and glucose, insulin and lipid abnormalities in men with myocardial infarction. Proc Natl Acad Sci USA 1977; 74: 1729-1733.
5. Singer P., Diagnosis of primary hyperlipoproteinemias. Z Gesamte Inn Med 1977; 32: 128.
6. Phillips GB., Sex hormones, risk factors and cardiovascular disease. Am J Med 1978; 65: 7-11.
7. Herman JB, Goldbourt U., Uric acid and diabetes: observations in a population study. Lancet 1982; 2: 240-243.
8. Reaven GM., Banting Lecture 1988. Role of insulin resistance in human disease. Nutrition 1997; 13: 65; discussion 4, 6.
9. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002; 106: 3143-3421.
10. Ford ES., Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 2005; 28: 2745-2749.
11. Gavrila D, Salmeron D, Egea-Caparros JM, et al. Prevalence of metabolic syndrome in Murcia Region, a southern European Mediterranean area with low cardiovascular risk and high obesity. BMC Public Health 2011; 11: 562.
12. Brietzke SA., Controversy in diagnosis and management of the metabolic syndrome. Med Clin North Am 2007; 91: 1041-1061.
13. Prabhakaran D, Reddy KS., The metabolic syndrome: looking beyond the debates. Clin Pharmacol Ther 2011; 90: 19-21.
14. Kahn R, Buse J, Ferrannini E, et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289-2304.
15. Reaven GM., The metabolic syndrome: time to get off the merry-go-round? J Intern Med 2011; 269: 127-136.
16. Martin SL., Mammalian hibernation: a naturally reversible model for insulin resistance in man? Diab Vasc Dis Res 2008; 5: 76-81.
17. Darwin C., On the origin of species by means of natural selection, or the preservation of favoured races in the struggle for life, 1st ed. London: John Murray; 1859.
18. Singer MA., Vampire bat, shrew, and bear: comparative physiology and chronic renal failure. Am J Physiol Regul Integr Comp Physiol 2002; 282: R1583-R1592.
19. Arrese EL, Soulages JL., Insect fat body: energy, metabolism, and regulation. Annu Rev Entomol 2010; 55: 207-225.
20. Weis-Fogh T., Fat combustion and metabolic rate of flying locusts (Schistocerca gregaria Forskal. Philos Trans R Soc Lond 1952; 237: 1-36.
21. Fishman AP, Galante RJ, Winokur AI., Estivation in the African Lungfish. Proc Am Philos Soc 1992; 136: 61-72.
22. Jonsson N, Jonsson B, Hansen LP., Changes in proximate composition and estimates of energetic costs during upstream migration and spawning in atlantic salmon salmo salar. J Anim Ecol 1997; 66: 425-436.
23. McVeigh BR, Healey MC, Wolfe F., Energy expenditures during spawning by chum salmon Oncorhynchus keta (Walbaum) in British Columbia. J Fish Biol 2007; 71: 1696-1713.
24. Kubitzki K, Ziburski A., Seed dispersal in flood plain forests of Amazonia. Biotropica 1994; 26: 30-43.
25. Junk WJ., Temporary fat storage, an adaptation of some fish species to the waterlevel fluctuations and related environmental changes of the Amazon river. Amazoniana 1985; 9: 315-351.
26. Van Beurden EK., Energy metabolism of dormant Australian water-holding frogs (Cyclorana platycephalus). Copeia 1980; 4: 787-799.
27. Robin JP, Boucontet L, Chillet P, et al. Behavioral changes in fasting emperor penguins: evidence for a "refeeding signal" linked to a metabolic shift. Am J Physiol Regul Integ Comp Physiol 1998; 274: R746-R753.
28. Challet E, le Maho Y, Robin JP, et al. Involvement of corticosterone in the fasting-induced rise in protein utilization and locomotor activity. Pharmacol Biochem Behav 1995; 50: 405-412.
29. Klaasen M., Metabolic constraints on longterm migration in birds. J Exp Biol 1996; 199: 57-64.
30. Carey HV, Andrews MT, Martin SL., Mammalian hibernation: cellular and molecular responses to depressed metabolism and low temperature. Physiol Rev 2003; 83: 1153-1181.
31. Millar JS, Hickling GJ., Fasting endurance and the evolution of mammalian body size. Funct Ecol 1990; 4: 5-12.
32. Mrosovsky N, Sherry DF., Animal anorexias. Science 1980; 207: 837-842.
33. Hartman FA, Brownell KA., Liver lipids in hummingbirds. Condor 1959; 61: 270-277.
34. Hargrove JL., Adipose energy stores, physical work, and the metabolic syndrome: lessons from hummingbirds. Nutr J 2005; 4: 36.
35. Tryland M, Brun E., Serum chemistry of the minke whale from the northeastern Atlantic. J Wildl Dis 2001; 37: 332-341.
36. Otis JP, Sahoo D, Drover VA, et al. Cholesterol and lipoprotein dynamics in a hibernating mammal. PLoS ONE 2011; 6: e29111.
37. Florant GL, Lawrence AK, Williams K, et al. Seasonal changes in pancreatic B-cell function in euthermic yellow-bellied marmots. Am J Physiol Regul Integ Comp Physiol 1985; 249: R159-R165.
38. Bairlein F., How to get fat: nutritional mechanisms of seasonal fat accumulation in migratory songbirds. Naturwissenschaften 2002; 89: 1-10.
39. Shafrir E, Ziv E, Kalman R., Nutritionally induced diabetes in desert rodents as models of type 2 diabetes: Acomys cahirinus (spiny mice) and Psammomys obesus (desert gerbil). ILAR J 2006; 47: 212-224.
40. Frank N, Geor RJ, Bailey SR, et al. Equine metabolic syndrome. J Vet Intern Med 2010; 24: 467-475.
41. Neel JV., Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet 1962; 14: 353-362.
42. Wells JC., The evolution of human fatness and susceptibility to obesity: an ethological approach. Biol Rev Camb Philos Soc 2006; 81: 183-205.
43. Eknoyan G., A history of obesity, or how what was good became ugly and then bad. Adv Chronic Kidney Dis 2006; 13: 421-427.
44. Prentice AM, Hennig BJ, Fulford AJ., Evolutionary origins of the obesity epidemic: natural selection of thrifty genes or genetic drift following predation release? Int J Obes (Lond) 2008; 32: 1607-1610.
45. Benyshek DC, Watson JT., Exploring the thrifty genotype's food-shortage assumptions: a cross-cultural comparison of ethnographic accounts of food security among foraging and agricultural societies. Am J Phys Anthropol 2006; 131: 120-126.
46. Chakravarthy MV, Booth FW., Eating, exercise, and "thrifty" genotypes: connecting the dots toward an evolutionary understanding of modern chronic diseases. J Appl Physiol 2004; 96: 3-10.
47. Speakman JR., Thrifty genes for obesity, an attractive but flawed idea, and an alternative perspective: the 'drifty gene' hypothesis. Int J Obes (Lond) 2008; 32: 1611-1617.
48. Johnson RJ, Andrews P, Benner SA, et al. Theodore e. Woodward award: the evolution of obesity: insights from the mid- miocene. Trans Am Clin Climatol Assoc 2010; 121: 295-305; discussion 8.
49. Oda M, Satta Y, Takenaka O, et al. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol 2002; 19: 640-653.
50. Johnson RJ, Gaucher EA, Sautin YY, et al. The planetary biology of ascorbate and uric acid and their relationship with the epidemic of obesity and cardiovascular disease. Med Hypotheses 2008; 71: 22-31.
51. Skinner MF, Dupras TL, Moya-Sola S., Periodicity of linear enamel hypoplasia among Miocene Dryopithecus from Spain. J Paleopathol 1995: 195-222.
52. Andrews P, Kelley J., Middle Miocene dispersals of apes. Folia primatologica. Int J Primatol 2007; 78: 328-343.
53. Begun DR., Middle Miocene hominoid origins. Science 2000; 287: 2375.
54. Johnson RJ, Andrews P., Fructose, uricase, and the back-to-africa hypothesis. Evol Anthropol 2010; 19: 250-257.
55. Xu CF, Yu CH, Xu L, et al. Hypouricemic therapy: a novel potential therapeutic option for nonalcoholic fatty liver disease. Hepatology 2010; 52: 1865-1866.
56. Nakagawa T, Hu H, Zharikov S, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006; 290: F625-F631.
57. Baldwin W, McRae S, Marek G, et al. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes 2011; 60: 1258-1269.
58. Grayson PC, Kim SY, Lavalley M, et al. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2011; 63: 102-110.
59. Masuo K, Kawaguchi H, Mikami H, et al. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003; 42: 474-480.
60. Kodama S, Saito K, Yachi Y, et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care 2009; 32: 1737-1742.
61. Lee K., Relationship between uric acid and hepatic steatosis among Koreans. Diabetes Metab 2009; 35: 447-451.
62. Shafiu M, Johnson RJ, Turner ST, et al. Urate transporter gene SLC22A12 polymorphisms associated with obesity and metabolic syndrome in Caucasians with Hypertension. Kidney Blood Press Res 2012; 35: 477-482.
63. Parsa A, Brown E, Weir MR, et al. Genotype-based changes in serum uric acid affect blood pressure. Kidney Int 2012; 81: 502-507.
64. Caulfield MJ, Munroe PB, O'Neill D, et al. SLC2A9 is a high-capacity urate transporter in humans. PLoS Med 2008; 5: e197.
65. Yang Q, Kottgen A, Dehghan A, et al. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet 2010; 3: 523-530.
66. Feig DI, Soletsky B, Johnson RJ., Effect of allopurinol on the blood pressure of adolescents with newly diagnosed essential hypertension. JAMA 2008; 300: 922-930.
67. Ogino K, Kato M, Furuse Y, et al. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study. Circ Heart Fail 2010; 3: 73-81.
68. Ishimoto T, Lanaspa M, Le M, et al. Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome. Proc Natl Acad Sci USA; in press.
69. Lanaspa M, Tapia E, Soto V, et al. Uric acid and fructose: potential biological mechanisms. Sem Nephrol; in press.
70. Lanaspa MA, Sanchez-Lozada LG, Choi YJ, Cicerchi C, Kanbay M, Roncal-Jimenez CA, et al. Uric acid induces Hepatic Steatosis by Generation of Mitochondrial Oxidative Stress: Potential Role in Fructose-Dependent and-Independent Fatty Liver. J Biol Chem. 2012 Oct 3
71. Lanaspa MA, Sanchez-Lozada LG, Cicerchi C, Li N, Roncal-Jimenez CA, Ishimoto T, et al. Uric Acid stimulates fructokinase and accelerates fructose metabolism in the development of Fatty liver. PLoS ONE. 2012; 7 (10): e47948
72. Abdelmalek MF, Lazo M, Horska A, et al. Higher dietary fructose is associated with impaired hepatic ATP homeostasis in patients with nonalcoholic fatty liver disease. Hepatology; in press.
73. Johnson RJ, Titte S, Cade JR, et al. Uric acid, evolution and primitive cultures. Semin Nephrol 2005; 25: 3-8.
74. Johnson RJ, Sautin YY, Oliver WJ, et al. Lessons from comparative physiology: could uric acid represent a physiologic alarm signal gone awry in western society? J Comp Physiol B 2009; 179: 67-76.
75. Johnson RJ, Perez-Pozo SE, Sautin YY, et al. Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev 2009; 30: 96-116.
76. Johnson RJ, Segal MS, Sautin Y, et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 2007; 86: 899-906.
77. Hu FB, Malik VS., Sugar-sweetened beverages and risk of obesity and type 2 diabetes: epidemiologic evidence. Physiol Behav 2010; 100: 47-54.
78. Malik VS, Popkin BM, Bray GA, et al. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 2010; 33: 2477-2483.
79. Malik VS, Popkin BM, Bray GA, et al. Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 2010; 121: 1356-1364.
80. Schulze MB, Manson JE, Ludwig DS, et al. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 2004; 292: 927-934.
81. Shapiro A, Mu W, Roncal C, et al. Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding. Am J Physiol Regul Integr Comp Physiol 2008; 295: R1370-R1375.